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The propagation of embryonic stem (ES) cells in an undifferentiated pluripotent state is dependent on
leukemia inhibitory factor (LIF) or related cytokines. These factors act through receptor complexes containing
the signal transducer gp130. The downstream mechanisms that lead to ES cell self-renewal have not been
delineated, however. In this study, chimeric receptors were introduced into ES cells. Biochemical and
functional studies of transfected cells demonstrated a requirement for engagement and activation of the latent
trancription factor STAT3. Detailed mutational analyses unexpectedly revealed that the four STAT3 docking
sites in gp130 are not functionally equivalent. The role of STAT3 was then investigated using the dominant
interfering mutant, STAT3F. ES cells that expressed this molecule constitutively could not be isolated. An
episomal supertransfection strategy was therefore used to enable the consequences of STAT3F expression to
be examined. In addition, an inducible STAT3F transgene was generated. In both cases, expression of STAT3F
in ES cells growing in the presence of LIF specifically abrogated self-renewal and promoted differentiation.
These complementary approaches establish that STAT3 plays a central role in the maintenance of the
pluripotential stem cell phenotype. This contrasts with the involvement of STAT3 in the induction of
differentiation in somatic cell types. Cell type-specific interpretation of STAT3 activation thus appears to be
pivotal to the diverse developmental effects of the LIF family of cytokines. Identification of STAT3 as a key
transcriptional determinant of ES cell self-renewal represents a first step in the molecular characterization of
pluripotency.
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Embryonic stem (ES) cells are pluripotent cell lines de-
rived by culture of preimplantation mouse embryos
(Evans and Kaufman 1981; Martin 1981; Brook and Gard-
ner 1997). At present, ES cells are the only nontrans-
formed mammalian stem cells that can be continuously
propagated in vitro. ES cell self-renewal is sustained by
the cytokine leukemia inhibitory factor (LIF) (Smith and
Hooper 1987; Smith et al. 1988; Williams et al. 1988).
The effect of LIF is to inhibit differentiation and support
proliferation of undifferentiated stem cells. However,
the mechanisms underlying the maintenance of pluripo-
tency during proliferative expansion remain elusive. We
are attempting to define those signaling processes down-
stream of the LIF receptor complex that direct ES cell
self-renewal. Elucidation of these principles will provide
a molecular model for stem cell regulation in mammals.
Insights provided by such a model should also be directly
applicable to the extension of ES cell technology to non-
mouse species.
The actions of LIF are mediated via heterodimeriza-
tion of two members of the class I cytokine receptors,
the low-affinity LIF receptor (LIF-R) and gp130 (Gearing
et al. 1991; Gearing and Bruce 1992; Davis et al. 1993).
The LIF-related cytokines, oncostatin M (OSM), cardio-
trophin (CT-1), and ciliary neurotrophic factor (CNTF),
act through the same receptor complex (in the case of
CNTF, additionally including the CNTF-Ra subunit)
and can similarly sustain ES cell self-renewal (Conover
et al. 1993; Rose et al. 1994; Wolf et al. 1994; Yoshida et
al. 1994; Pennica et al. 1995b). Furthermore, ES cells can
also be derived and maintained using a combination of
interleukin-6 and soluble interleukin-6 receptor (IL-6/
sIL-6R) (Nichols et al. 1994; Yoshida et al. 1994). In this
case, signaling is initiated via formation of gp130 ho-
modimers without involvement of LIF-R (Murakami et
al. 1993; Yoshida et al. 1994). Signals that emanate from
gp130 are therefore sufficient for self-renewal.
gp130 mediates cellular responses to IL-6 and IL-11 in
addition to the LIF-related cytokines (Kishimoto et al.
1994). All of these factors exert pleiotropic effects on
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diverse cell types in vitro and in vivo. In addition to ES
cell self-renewal, stimulation of gp130 receptor com-
plexes causes differentiation and growth inhibition in
M1 myeloid leukemic cells (Tomida et al. 1984), induc-
tion of acute phase gene expression in hepatocytes (Bau-
mann and Wong 1989), cholinergic differentiation of
sympathetic neurons (Yamamori et al. 1989), survival of
motor neurons (Li et al. 1995), proliferative and hyper-
trophic responses in cardiomyocytes (Hirota et al. 1995;
Pennica et al. 1995a; Yoshida et al. 1996), and astrocyte
differentiation of neuroepithelial progenitors (Bonni et
al. 1997; Koblar et al. 1998).
Signaling processes downstream of gp130 are complex
and are not yet fully characterized. Ligand-induced
dimerization of the receptors (Davis et al. 1993; Mu-
rakami et al. 1993) leads to phosphorylation and activa-
tion of associated JAK tyrosine kinases (Narazaki et al.
1994; Stahl et al. 1994). The cytoplasmic domain of
gp130 contains several tyrosine residues that are phos-
phorylated by the activated JAKs. These phosphotyro-
sine residues then interact with SH2 domain containing
proteins that in turn themselves become targets for JAKs
and possibly other nonreceptor tyrosine kinases. Conse-
quences include activation of the Ras mitogen-activated
protein (MAP) kinase (ERK) signaling cascade (Boulton et
al. 1994; Yin and Yang 1994; Sheng et al. 1997) and of the
STAT factors STAT1 and STAT3 (Lutticken et al. 1994;
Stahl et al. 1995). STAT proteins are latent transcription
factors that upon phosphorylation, dimerize and translo-
cate to the nucleus where they activate target gene tran-
scription (for review, see Ihle 1996). In myeloid leukemic
M1 cells, activation of STAT3 appears to be the main
effector of the differentiation response to IL-6 or LIF
(Minami et al. 1996; Nakajima et al. 1996). STAT3 acti-
vation has also been adduced to mediate CNTF or LIF-
induced differentiation of neuroepithelial precursors
into astrocytes (Bonni et al. 1997).
In this study we have examined the receptor require-
ments for self-renewal signaling in ES cells and deter-
mined a critical contribution of STAT3 activation. In
contrast to its role in somatic cells, activated STAT3
acts to suppress differentiation in ES cells.
Results
Granulocyte colony-stimulating factor receptor can
signal ES cell self-renewal
Granulocyte colony-stimulating factor receptor (G-CSF-
R) is a class I cytokine receptor that is evolutionarily
related to gp130 and LIF-R (Gearing et al. 1991; Cham-
bers et al. 1997). G-CSF-R is not present in ES cells. To
begin delineating the signaling requirements for ES cell
propagation, the capacity of these related receptors to
sustain self-renewal was compared directly.
G-CSF-R undergoes ligand-induced homodimerization
to produce an active signaling complex. G-CSF respon-
siveness can therefore be conferred on cytoplasmic do-
mains of heterologous receptors through construction of
appropriate fusions. cDNAs encoding full-length G-
CSF-R cDNA and fusions between the extracellular por-
tion of G-CSF-R and the transmembrane and cytoplas-
mic region of gp130 or LIF-R were cloned into the ex-
pression vector pPCAGIZ. Plasmids were introduced
into LIF-R-deficient ES cells to eliminate the contribu-
tion of autocrine LIF signaling (Rathjen et al. 1990) from
subsequent analyses. In this and all other experiments,
ES cells were grown without feeder layers (Smith 1991).
Transfectants were selected and expanded in the pres-
ence of IL-6/sIL-6R, acting through endogenous gp130,
to avoid any selective pressure for adaptation to the in-
troduced receptor.
Stable transfectants were then plated at clonal density
in the absence of cytokine or presence of IL-6/sIL-6R or
G-CSF. The number of stem cell colonies generated was
scored after 6 days. The data in Figure 1A show that the
G-CSF-R/gp130 chimeric receptor sustained stem cell
propagation in response to G-CSF. This result is an-
Figure 1. ES cell self-renewal and induction of STAT DNA-
binding activity mediated by G-CSF-R wild-type, truncated, and
chimeric cytokine receptors. (A) Efficiency of clonal stem cell
renewal in response to G-CSF measured by formation of alka-
line phosphatase-positive colonies. (Light gray bars) −G-CSF;
(dark gray bars) +G-CSF. Data are mean ± S.E.M. of triplicate de-
terminations on single representative clones normalized to re-
sponse to IL-6/sIL-6R. (B) Induction of STAT DNA binding by
IL-6/sIL-6R and G-CSF determined by electophoretic mobility-
shift assay. Cells were untreated or stimulated for 30 min with
IL-6/sIL-6R or G-CSF (30 ng/ml). Nuclear extracts were pre-
pared and assayed for SIE binding. Note the absence of detect-
able STAT1/STAT3 heterodimer complex on stimulation of
full-length G-CSF-R.
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ticipated from previous findings on the capacity of gp130
homodimers to signal self-renewal (Yoshida et al. 1994).
The G-CSF-R/LIF-R chimera did not support formation
of stem cell colonies despite higher levels of cell surface
expression measured by radioligand binding (not shown).
This is in line with previous reports that homodimeriza-
tion of the LIF-R cytoplasmic domain results in quanti-
tatively (Baumann et al. 1994a; Stahl et al. 1995) and
qualitatively (Stahl et al. 1995) diminished activation of
downstream pathways compared with LIF-R/gp130 het-
erodimerization or gp130 homodimerization. However,
ES cells transfected with G-CSF-R did form stem cell
colonies in response to G-CSF-R though with lower ef-
ficiency than cells expressing the G-CSF-R/gp130 chi-
mera. This somewhat surprising finding corroborates
similar data reported recently (Starr et al. 1997). Propa-
gation of the G-CSF-R transfectants remained factor de-
pendent, and the cells differentiated normally when de-
prived of cytokine.
The finding that G-CSF-R is competent to maintain
the stem cell phenotype suggests that the signaling in-
teractions essential for ES cell self-renewal are preserved
between gp130 and G-CSF-R. Conserved features in the
intracellular domains of these two receptors are not
readily identifiable because of extensive sequence diver-
gence. However, G-CSF-R contains a putative STAT
binding site and is thought to signal primarily through
activation of STAT3 (Shimozaki et al. 1997). Electropho-
retic mobility-shift assays were performed to determine
the induction of nuclear STAT DNA-binding activity by
G-CSF in the various ES cell transfectants. Significant
STAT3 activation was evident in ES cells transfected
with expression vectors for the G-CSF-R/gp130 chimera
or the full-length G-CSF-R. In contrast, ES cells express-
ing the G-CSF-R/LIF-R chimera showed only weak in-
duction of STAT3 DNA-binding activity in response to
G-CSF (Fig. 1B). Antibody supershift experiments (not
shown) confirmed that the DNA-binding complex con-
sisted predominantly of STAT3 homodimers with a mi-
nor component of STAT3/STAT1 heterodimer as de-
scribed previously in ES cells and other systems (Hocke
et al. 1995; Stahl et al. 1995; Starr et al. 1997). These
observations pointed to a potentially critical role for
STAT3 activation in mediation of the self-renewal signal.
STAT3 docking sites on gp130 are required to signal
ES cell self-renewal
The cytoplasmic domain of mouse gp130 contains seven
tyrosine residues. Four of these have been identified as
phosphorylation-dependent sites of interaction with
STAT3 (Stahl et al. 1995). Substitution of these tyrosine
residues with phenylalanine in the context of the G-CSF-
R/gp130 chimera was therefore used to determine their
significance for self-renewal signaling. The modified chi-
meric receptor expression constructs were introduced
into DO27 ES cells. These cells are LIF-deficient because
of targeted deletion of both gene copies and, in addition,
carry a b-galactosidase reporter integrated into one allele
of the Oct-4 gene (C. Dani, I. Chambers, S. Johnstone, M.
Robertson, B. Ebrahimi-Chahardahcherik, M. Saito, T.
Taga, M. Li, T. Burdon, J. Nichols, and A.G. Smith, in
prep.). This reporter is expressed only in undifferentiated
ES cells (Mountford et al. 1994). Self-renewal was as-
sayed both by measuring b-galactosidase activity in me-
dium density cultures (Fig. 2B) and by scoring formation
of alkaline phosphatase positive colonies at clonal den-
sity (Fig. 2C). Three independent transfectant clones
were analyzed for each receptor. The data summarized in
Figure 2 demonstrate that the presence of STAT3 dock-
ing sites is essential for stem cell propagation.
The intact gp130 cytoplasmic domain mediated a clear
induction of SIE DNA-binding activity (Fig. 2D). Muta-
tion of individual docking sites had no appreciable effect.
However, mutation of all four sites eliminated both the
self-renewal signal and the induction of STAT3 DNA-
binding activity. Radioligand binding established that
cell surface expression was not limiting for any of the
receptors (not shown). To confirm that other signaling
pathways are not impaired by mutation of the STAT3
docking sites, we examined activation of the ERK cas-
cade. ERK activation requires receptor phosphorylation
on tyrosine 118 by JAK kinases and recruitment of SHP2
(Stahl et al. 1995; Fukada et al. 1996). Figure 2E shows
that the basal level of constitutive ERK activity was sig-
nificantly enhanced by stimulation of chimeric receptors
in all transfectants tested. In particular, the two recep-
tors, Y265/275F and Y126-275F, which gave reduced ac-
tivation of STAT3 and cannot signal self-renewal, medi-
ated normal and heightened levels of ERK activation,
respectively. Therefore, there is no general compromise
in the signaling capacity of these molecules.
Interestingly, this data also indicates that the STAT3
sites in gp130 may not be equivalent in vivo. Specifi-
cally, mutation of the two adjacent carboxy-terminal
STAT3 binding sites (Y265 and Y275) abolished self-
renewal signaling, whereas mutation of the two-mem-
brane proximal sites had little effect. This difference cor-
related with the lower induction of STAT3 DNA-bind-
ing activity and the specific reduction in STAT3 phos-
phorylation relative to ERK phosphorylation (Figs. 2D,E)
(see Discussion). Self-renewal thus appears to require an
appreciable level of STAT3 activation.
Inhibition of STAT3 activation blocks self-renewal
and promotes differentiation
The above findings indicated that STAT3 may play a key
role in ES cell signaling. To assess directly the require-
ment for STAT3 activation in ES cell self-renewal, we
exploited a dominant interfering mutant form of STAT3,
STAT3F. In this mutant (Minami et al. 1996), the tyro-
sine residue at amino acid position 705 is mutated to
phenylalanine. Phosphorylation of Tyr705 is required for
dimerization and nuclear translocation. When expressed
at high levels, STAT3F has been shown to block the
activation of endogenous STAT3 in various cell types,
possibly by titrating out receptor docking sites (Fukada
et al. 1996; Minami et al. 1996; Nakajima et al. 1996;
Bonni et al. 1997; Ihara et al. 1997).
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2050 GENES & DEVELOPMENT
Using conventional transfection approaches, we were
unable to recover ES cell transfectants showing stable
high-level expression of STAT3F. In parallel experi-
ments, however, transfection of the LIF-independent em-
bryonal carcinoma cell line P19 yielded multiple ex-
pressing clones. This suggested that blockade of STAT3
activation in ES cells specifically resulted in cell death,
growth arrest, or differentiation. An alternative transfec-
tion and expression strategy was therefore adopted to
enable characterization of the consequences of STAT3F
expression. The approach, termed supertransfection, re-
lies on expression of polyoma virus large T protein by the
recipient ES cells and its interaction with a polyoma ori-
gin of replication present in the transfected DNA. This
results in efficient episomal propagation of incoming
plasmid (Gassmann et al. 1995). We have developed this
system for efficent cDNA expression in ES cells (H.
Niwa, I. Chambers, L. Forrester, M. Gassmann, and A.G.
Smith, in prep.). The process yields at least 100-fold
more stable transfectants than conventional transfection
protocols. A second important advantage of episomal su-
pertransfection is that the unpredictable effects of chro-
mosomal integration are avoided, with the result that
the level of expression is both stable and relatively uni-
form (H. Niwa, I. Chambers, L. Forrester, M. Gassmann,
and A.G. Smith, in prep.).
The STAT3F mutant cDNA was introduced into the
supertransfection vector pHPCAG. The wild-type
STAT3 coding sequence was also introduced, in both
sense and antisense orientations. The three constructs
were electroporated into MG1.19 cells that harbor a large
T expression plasmid and can be supertransfected with
constructs containing the polyoma origin (Gassmann et
al. 1995). Supertransfectants were isolated by selection
in hygromycin B for 8 days in the presence of LIF. Colo-
nies were fixed, stained with Leishman’s reagent,
counted, and scored for the presence of stem cells and
differentiated cells. More than 95% of colonies obtained
following supertransfection with control or wild-type
STAT3 vector were stem cell colonies (Fig. 3A). A mod-
est increase in the proportion of differentiated colonies
was obtained with the antisense construct. The STAT3F
vector, however, yielded predominantly differentiated
colonies. A decrease in total number of colonies was also
observed after supertransfection with STAT3F. This may
reflect an early onset of differentiation that would pro-
duce very small clones that would not be scored. Alter-
natively, very high levels of STAT3F expression may
also be toxic, though this has not been reported in other
cell types. Morphologically, the differentiated STAT3F
colonies closely resembled the differentiated colonies
generated on culture of ES cells in the absence of LIF (Fig.
Figure 2. Effect of mutating STAT3 in-
teraction sites in gp130 on ES cell self-re-
newal and induction of STAT3 DNA-bind-
ing activity. (A) Schematic of the various
chimeric receptors indicating the tyrosine-
–phenylalanine substitutions introduced
into the wild-type (278) gp130 cytoplasmic
domain. Numbering commences with the
first residue of the 278-amino-acid intra-
cellular domain of mouse gp130. The phe-
nylalanine (F) for tyrosine (Y) substitu-
tions in the four STAT3 docking sites
are indicated. The additional three ty-
rosines do not interact with STAT3 (Stahl
et al. 1995). (B) Stem cell renewal medi-
ated by chimeric receptors in response to
G-CSF measured by b-galactosidase ex-
pression from the Oct-4 locus. Data are
mean ± S.E.M. for duplicate determinations
on three independent clones normalized
relative to response to IL-6/sIL-6R. (C) Ef-
ficiency of clonal stem cell renewal medi-
ated by chimeric receptors in response to
G-CSF measured by formation of alkaline
phosphatase positive colonies. Data are
mean ± S.E.M. for duplicate assays on three
independent clones normalized relative to
response to IL-6/sIL-6R. (D) Electrophoret-
ic mobility-shift assay of induced STAT3
DNA binding. Transfected clones were
left untreated (lane 1) or stimulated for 30
min with IL-6/sIL-6R (lane 2) or with G-CSF at 30 ng/ml (lane 3) or 3 ng/ml (lane 4). Nuclear extracts were assayed for SIE binding.
(E) Immunoblot of STAT3 and ERK phosphorylation induced by G-CSF stimulation of chimeric receptors. Transfected clones were left
untreated (lane 1) or were stimulated for 20 min with IL-6/sIL-6R (lane 2) or with G-CSF (lane 3). Immunoblots of cell lysates were
probed sequentially with antibodies specific for the active phosphorylated forms of ERK and STAT3.
STAT3 and ES cell pluripotency
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3C). Various other cDNAs have been expressed in ES
cells using this system, with little or no effect on forma-
tion of stem cell colonies (data not shown). This sug-
gested that the effect on differentiation was specifically
attributable to expression of STAT3F.
The differentiation induced by expression of STAT3F
was examined further by expression analysis of the
marker genes rex1 and H19. Rex-1 mRNA, which is spe-
cifically expressed in undifferentiated stem cells, was
down-regulated in STAT3F supertransfectants. In con-
trast, H19 RNA, which is found at low levels in stem
cells but is up-regulated during differentiation, was in-
creased (Fig. 3B). A similar pattern of gene regulation is
observed during differentiation of ES cells induced by
withdrawal of LIF. These data confirm that the morpho-
logical differentiation triggered by STAT3F is accompa-
nied by reprogramming of gene expression.
STAT3F was also expressed from the mouse phospho-
glycerate kinase (pgk-1) promoter in the episomal vector
pHPPGK. This vector gives at least 10-fold lower expres-
sion than pHPCAG (H. Niwa, I. Chambers, L. Forrester,
M. Gassmann, and A.G. Smith, in prep.). In this case,
there was no significant effect on either colony number
or differentiation status of MG1.19 supertransfectants. A
relatively high level of expression of the dominant inter-
fering mutant therefore appears necessary to block self-
renewal.
Effect of STAT3F on self-renewal is suppressed
by coexpression of STAT3
To test whether the induction of differentiation by ex-
pression of STAT3F was due to an inhibition of endog-
enous STAT3 activity, we attempted to rescue the stem
cell phenotype by coexpression of wild-type STAT3 and
also of STAT1 and STAT4. A STAT3F expression vector
carrying a blasticidin resistance marker was cosuper-
transfected into MG1.19 cells with episomal constructs
for expression of wild-type STATs and hygromycin re-
sistance. Cosupertransfectants were isolated in medium
containing both 20 µg/ml blasticidin S and 80 µg/ml of
hygromycin B. The numbers of stem cell and differenti-
ated colonies were scored after 8 days. As shown in Fig-
ure 4, only coexpression of wild-type STAT3 restored
self-renewal in the presence of STAT3F. Transfection
with STAT1 or STAT4 constructs alone had no effect on
self-renewal in the absence of STAT3F (not shown) and
did not alter differentiation induced by STAT3F. In the
case of supertransfection with the CAG promoter
STAT1 construct, the total number of colonies (stem
plus differentiated) recovered was reduced, but the rela-
tive proportion of stem cell colonies versus differenti-
ated cells was unaltered. This occurred in both the pres-
ence and absence of coexpression of STAT3F and sug-
gests that high-level expression of STAT1 may be toxic
to ES cells. By using the mouse PGK-1 promoter to drive
lower levels of expression (H. Niwa, I. Chambers, L. For-
rester, M. Gassmann, and A.G. Smith, in prep.), compa-
rable numbers of colonies were recovered on transfection
with the STAT1 as with the other constructs. In this
case, again only the STAT3 construct showed any resto-
ration of stem cell colonies, although to a lower degree
than with the high-expression CAG vector (not shown).
These data indicate that STAT3 has a specific function
in ES cells that cannot be compensated by STAT1 or
STAT4 (see Discussion).
Figure 3. Induction of differentiation by expression of STAT3F
in MG1.19 ES cells. (A) Proportion of differentiated colonies in
LIF-supplemented medium resulting from supertransfection of
STAT3, antisense STAT3, and STAT3F expression vectors.
Colonies were fixed and stained with Leishman’s reagent after 8
days of selection, and the numbers of stem cell colonies and
differentiated colonies were scored. (B) Marker gene expression
in STAT3F supertransfectants. Expression of marker genes in
pools of MG1.19 cells supertransfected with STAT3 (lane 1),
STAT3 antisense (lane 2), and STAT3F (lane 3) expression vec-
tors. Total RNA was prepared after 8 days of selection in LIF-
supplemented medium, and 5-µg aliquots were analyzed by fil-
ter hybridization with b-globin, Rex-1, H19, and G3PDH
probes. The b-globin probe detects all transgene mRNA species
generated from pHPCAG, including an alternatively spliced
product from the antisense contruct. (C) Photomicrographs of
representative colonies 8 days after supertransfection with (i)
STAT3, (ii) STAT3F, and (iii) empty expression vectors and se-
lection in the presence of LIF, or (iv) induction of differentiation
by culture in the absence of LIF for 8 days.
Niwa et al.
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Generation of an inducible STAT3F transgene
integration in ES cells
The effect of STAT3F expression on endogenous STAT3
activity could not be monitored directly in undifferenti-
ated ES cells because ES cells expressing appreciable
STAT3F constitutively could not be propagated. This re-
quired the generation of an inducible transgene. The tet-
racycline-regulatable system (tet-off) developed by Bu-
jard and colleagues (Gossen and Bujard 1992) has been
shown to confer inducibility on transgene expression in
several cell types in culture and in the intact animal.
However, it has proven problematic to establish this
two-component system in ES cells. This is probably due
to a combination of the relatively toxic effects of the tet
repressor–VP16 fusion (tTA) and the tendency of ES cells
to suppress expression of integrated transgenes (silenc-
ing). We have isolated previously an ES cell line, ZHTc6,
that maintains stable production of effective but non-
toxic levels of tTA from a gene trap integration (H. Niwa
and A. Smith, in prep.). This cell line also contains a
tetracycline-responsive hCMV*-1 transgene integrated
at a favorable expression site. Expression of such trans-
genes is usually deregulated and/or mosaic in ES cells
because of the sensitivity of the hCMV*-1 promoter to
site of integration effects and silencing. However, trans-
gene expression in line ZHTc6 is completely repressed in
the presence of tetracycline but is activated in all cells
on withdrawal of tetracycline as revealed by b-galacto-
sidase reporter expression (H. Niwa and A. Smith, in
prep.). Because of the low efficiency of establishing de
novo transgene integrations with such favorable charac-
teristics, we adopted a transgene substitution approach
to generate an inducible STAT3F transgene.
A targeting vector was designed for introduction of the
STAT3F sequences into the hCMV*-1 locus by homolo-
gous recombination, using 58 and 38 sequences from the
original transgenic construct as homology arms (Fig. 5A).
In the presence of tetracycline, ZHTc6 cells are sensitive
to G418 because the hCMV*-1 promoter is repressed.
Advantage was taken of this by including a constitutive
MC1 enhancer/promoter in the supertargeting vector to
drive selectable marker expression. The absence of the
neo sequence, however, requires that a legitimate recom-
bination event with the resident transgene occur to con-
fer G418 resistance. This powerful selection facilitated
the isolation of targeted clones in which the STAT3F
sequence was faithfully integrated 38 to the hCMV*-1
promoter (Fig. 5B). In the continued presence of tetracy-
cline, the targeted cells were maintained readily as un-
Figure 5. Generation of an inducible STAT3F transgene inte-
gration by supertargeting. (A) Schematic of supertargeting strat-
egy for introduction of STAT3F into a tetracycline-regulatable
expression site. ZHTc6 ES cells contain a tetracycline-regulated
transgene comprising the hCMV*-1 promoter (Gossen and Bu-
jard 1992), b-globin second intron, Oct-4 open reading frame
(Okazawa et al. 1991), and IRESbgeopA selection marker
(Mountford et al. 1994). Homologous recombination can be
used to replace the Oct-4 sequence (supertargeting). Use of a
truncated selection marker in the targeting vector facilitates the
isolation of homologous recombinants. ZHTc6 cells were elec-
troporated with the STAT3F–SuperKO vector and selected in
G418 in the presence of tetracycline. G418-resistant clones
were duplicated and screened for sensitivity against gancyclovir
to enrich further for homologous recombinants. The option of
excising the loxP-flanked MC1tk cassette by transient expres-
sion of Cre recombinase was not pursued. (B) Diagnosis of the
supertargeting event in Gs ES cells. Gancyclovir-sensitive (Gs;
lanes 1–4) and -resistant (Gr; lane 5) clones were analyzed by
Southern hybridization. A 3.2-kb SacI fragment was detected
with a probe from the 58 end of lacZ in the Gs samples, indica-
tive of the correct replacement of the Oct-4 cDNA sequence
with STAT3F sequence. The Gr clone retained the 4.8-kb frag-
ment diagnostic for the original Oct-4 transgene integration in
ZHTc6 cells.
Figure 4. Cosupertransfection of STAT3F with wild-type
STAT expression vectors. Proportions of undifferentiated stem
cell colonies generated after cosupertransfection of MG1.19 ES
cells with 10 µg of pBPCAGGS–STAT3F plus 10 µg of pHPCAG
vector containing stuffer (control), STAT3, STAT1, or STAT4
inserts. After 8 days of selection with 80 µg/ml of hygromycin
B plus 20 µg/ml of blasticidin S, colonies were fixed and stained
with Leishman’s reagent.
STAT3 and ES cell pluripotency
GENES & DEVELOPMENT 2053
differentiated stem cell colonies in the presence of LIF.
Three clones, Gs1, Gs2, and Gs3, were then analyzed
further.
Induced expression of STAT3F blocks ES cell
self-renewal and causes differentiation
Withdrawal of tetracycline from Gs1, Gs2, or Gs3 cells
resulted in the induction of differentiation in all three
clones (Fig. 6A–C). Importantly, the efficiency of colony
formation was not significantly different in the presence
or absence of tetracycline, indicating that there is no
toxic effect of STAT3F induction. The induced cultures
differentiated over a 3- to 4-day time period, paralleling
the behavior of parental ES cells on removal of LIF
(Smith 1991). The differentiation response was con-
firmed by Northern hybridization analysis of Rex-1 and
H19 transcripts (data not shown).
Mobility retardation analysis was used to investigate
directly STAT3 activation in STAT3F-expressing ES
cells. The data in Figure 6D show that the level of
STAT3 DNA-binding activity induced by gp130 stimu-
Figure 6. Induced expression of STAT3F causes ES cell differentiation and inhibits STAT3 activation. (A) Differentiation of Gs ES
cells induced by withdrawal of tetracycline. Gs ES cells grown up in the presence of tetracycline were plated at clonal density (500
cells/60-mm dish) in LIF-supplemented medium in the presence or absence of tetracycline (1 µg/ml). After 6 days, colonies were fixed
and stained with Leishman’s reagent. The histogram records the proportions of differentiated colonies for three independent clones,
Gs1 (solid bars), Gs2 (hatched bars), and Gs3 (shaded bars). (B) Dose response curve of Gs2 cell differentiation. Gs2 ES cells were
cultured as above in the presence of the indicated concentrations of tetracycline, then fixed, stained, and scored. (C) Photomicrographs
of uninduced and induced Gs2 ES cells. Representative colonies of Gs2 cells cultured for 6 days in LIF-supplemented medium in the
presence (+Tc) or absence (−Tc) of tetracycline (1 µg/ml) and then fixed and stained with Leishman’s reagent. (D) Mobility retardation
assay of STAT3 DNA-binding activity in noninduced and induced Gs2 cells. Gs2 ES cells were cultured for 72 hr in the presence or
absence of tetracycline. IL-6/sIL-6R was withdrawn for the final 24 hr, then restored for the indicated times. Nuclear extracts were
prepared and assayed as described for SIE DNA-binding activity. (E) Quantitation of STAT3 SIE binding by PhosphorImager. (Shaded
bars) +Tc; (open bars) −Tc.
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lation was significantly lower in the presence of
STAT3F. Quantitative PhosphorImager analysis con-
firmed a reduction of 50% or greater in the gel shift sig-
nal at all time points (Fig. 6E). The presence of residual
STAT3 activity is consistent with the notion that a
threshold level of active STAT3 is required to sustain
self-renewal.
These findings confirm that expression of STAT3F in
ES cells reduces gp130-mediated activation of STAT3,
thereby blocking self-renewal and promoting differentia-
tion.
Discussion
The primary cytoplasmic signal transduction event ema-
nating from a ligand-activated LIF-R/gp130 complex in
ES cells as in other cell types is considered to be trans-
phosphorylation and activation of receptor-associated Ja-
nus kinases (JAKs) (Davis et al. 1993; Narazaki et al.
1994). The JAKs then phosphorylate tyrosine residues in
the receptors, creating docking sites for SH2 domain-
containing proteins, notably including the STAT factors
STAT1 and STAT3 (Lutticken et al. 1994; Stahl et al.
1995). STAT proteins are themselves targets for phos-
phorylation by JAKs, which leads to their dimerization
and translocation to the nucleus. Other signal transduc-
ing molecules can also be activated downstream of
gp130, including insulin receptor substrate-1 (IRS-1),
phosphoinositide-3 kinases (PI-3 kinase), nonreceptor ty-
rosine kinases such as Hck and Btk, the tyrosine phos-
phatase SHP2, and the mitogen-activated protein kinases
ERK1 and ERK2 (Boulton et al. 1994; Ernst et al. 1994;
Yin and Yang 1994; Argetsinger et al. 1995; Matsuda et
al. 1995a,b). This modular signaling system has been as-
sumed to underlie the diverse and pleiotropic effects of
IL-6 and LIF-related cytokines in different cell types. A
key issue therefore is to resolve the relative contribution
of different signaling pathways in any given responsive
cell type. A critical role has been ascribed to SHP2-me-
diated activation of the MAP kinase cascade in prolifera-
tion of BAF-BO3 cells (Fukada et al. 1996) and suppres-
sion of apoptosis in cardiomyocytes (Sheng et al. 1997).
In contrast, the differentiation responses of myeloid M1
cells (Minami et al. 1996; Nakajima et al. 1996) and pri-
mary neural precursors (Bonni et al. 1997) are effected via
activation of STAT3. Previous studies in ES cells have
suggested that JAK–STAT signaling, ERK activation, and
the nonreceptor tyrosine kinase Hck could all be in-
volved in LIF signaling (Ernst et al. 1994, 1996; Narazaki
et al. 1994; Hocke et al. 1995; Boeuf et al. 1997).
We initially investigated the ability of chimeric recep-
tor constructs to signal ES cell self-renewal by isolation
of stably expressing transfectants. The observation that
G-CSF-R can support ES cell propagation drew attention
to signaling features conserved between G-CSF-R and
gp130, notably the induction of STAT3 DNA-binding
activity. Combined substitutions of the tyrosine resi-
dues in the STAT3 binding sites of gp130 cytoplasmic
domain were associated with different levels of STAT3
activation and indicated that a self-renewal signal is as-
sociated with a threshold of STAT3 activity. Moreover,
the four STAT3 sites do not appear to act in either a
redundant or simple cumulative manner. Both self-re-
newal signaling and induction of STAT3 DNA-binding
activity were maintained on pairwise mutation of the
two-membrane proximal STAT3 docking sites (Y126 and
Y173) but not on mutation of the carboxy-terminal pair
(Y265 and Y275) (see Fig. 2). This observation is some-
what unexpected as it has been shown previously that
the isolated phosphopeptide sequences have equivalent
STAT3 binding properties (Stahl et al. 1995) and that a
truncated receptor with a single-membrane proximal
STAT3 site (Y126) can efficiently induce STAT3-medi-
ated differentiation of M1 cells (Yamanaka et al. 1996). It
is important to note, however, that in the truncated re-
ceptor, sequences that mediate receptor internalization
(Dittrich et al. 1996) have also been deleted with unpre-
dictable consequences for signaling properties. Our find-
ings indicate that in the normal context of the full-
length receptor, the four STAT3 docking sites are not
equivalent. The explanation for the reduced activity of
the membrane proximal pair of sites is unclear though
one possibility is that availability of Y126 may be influ-
enced by interaction of SHP2 with Y118 (note enhanced
ERK activation from Y126-275F chimera in Fig. 2E).
The finding that mutation of the STAT3 binding sites
in the cytoplasmic domain of gp130 abolished the self-
renewal signal prompted a direct investigation of the role
of this transcription factor. New strategies were required
to express the dominant interfering mutant STAT3F in
ES cells. The methods we have deployed in this study
enhance the experimental versatility and tractability of
ES cells and establish new avenues for the characteriza-
tion in vitro of gene functions involved in stem cell
propagation, commitment, or differentiation. Because of
the >100-fold increase in stable transfection efficiency
and the relative homogeneity of expression (H. Niwa, I.
Chambers, L. Forrester, M. Gassmann, and A.G. Smith,
in prep.), episomal supertransfection provides a method-
ology for the screening and analysis of cDNAs whose
expression is not compatible with ES cell self-renewal.
The first demonstration of effective operation of the tet-
racycline regulation system in ES cells provides a
complementary inducible expression approach. These
two methods should find broad application in functional
screening and in the genetic manipulation of lineage
commitment and differentiation processes in ES cells.
Both constitutive expression of STAT3F following epi-
somal supertransfection and induced expression from
the regulatable chromosomal site inhibited self-renewal
and resulted in differentiation. The episomal approach
also allowed the specificity of the requirement for
STAT3 to be established by coexpression of various
STAT family members with STAT3F. The finding that
STAT3 can restore self-renewal indicates that this factor
serves a specific and nonredundant function in ES cell
self-renewal in response to LIF. The evidence that
STAT1 cannot compensate for STAT3 is noteworthy be-
cause STAT1 can be activated in response to LIF in ES
cells, though to a much lesser extent than STAT3 (Starr
STAT3 and ES cell pluripotency
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et al. 1997). STAT1 may play little or no role in ES cell
propagation. Induction of STAT1 DNA-binding activity
was not evidently associated with self-renewal signaling
from the various chimeric receptors used in this study
(Figs. 1B and 2D). Furthermore, ES cells in which both
alleles of the stat1 gene have been inactivated are phe-
notypically normal (Durbin et al. 1996).
A role for STAT3 in ES cell signaling has recently also
been suggested by Boeuf et al. (1997) who reported the
isolation of ES cell clones expressing STAT3F constitu-
tively. These cells apparently showed an increased ten-
dency to differentiate after 1 month or more in culture.
The basis of this phenomenon is unclear because ab-
sence or blockade of LIF signaling results in complete
differentiation within a few days (Smith et al. 1988;
Williams et al. 1988; C. Dani, I. Chambers, S. Johnstone,
M. Robertson, B. Ebrahimi-Chahardahcherik, M. Saito,
T. Taga, M. Li, T. Burdon, J. Nichols, and A.G. Smith, in
prep.). We were unable to establish conventional trans-
fectants expressing significant levels of STAT3F. How-
ever, our data on both episomal and induced expression
demonstrate that STAT3F rapidly and efficiently blocks
ES cell self-renewal and triggers differentiation.
Our results establish that STAT3 activation is essen-
tial for LIF-R/gp130-mediated ES cell self-renewal.
STAT3 activity is regulated by phosphorylation on both
tyrosine and serine (Wen et al. 1995), and a constitu-
tively active mutant has not been described. An isoform
of STAT3, STAT3b, generated by alternative splicing, is
reported to show sustained activation properties
(Schaefer et al. 1995). ES cells supertransfected with a
STAT3b vector remained LIF dependent (data not
shown), however, indicating that this isoform does not
substitute for activated STAT3 in ES cells. This may be
because STAT3b appears to function by formation of
heterodimers with c-Jun (Schaefer et al. 1995), and it is
anticipated that the STAT3b/c-Jun complex regulates a
distinct spectrum of target genes compared with the
STAT3 homodimer. It is noteworthy, however, that ex-
pression of v-src in ES cells renders them LIF indepen-
dent (Boulter et al. 1991). v-Src has been shown to asso-
ciate with and cause constitutive activation of STAT3
(Cao et al. 1996).
The p42/p44 MAP kinase pathway (ERK1 and ERK2)
has been reported to be activated by LIF in ES cells as in
other cell types (Ernst et al. 1996; Boeuf et al. 1997). The
Ras–ERK cascade is coupled to gp130 via the adaptor
molecule SHP2 (Fukada et al. 1996; Yamanaka et al.
1996). SHP2 interacts with activated gp130 at phos-
phorylated tyrosine residue 118 (Stahl et al. 1995). Sig-
nificantly, mutation of this residue does not inhibit self-
renewal signaling in ES cells (T. Burdon, I. Chambers, C.
Stracey, J. Nichols, and A.G. Smith, in prep.). Further-
more, the MEK inhibitor PD098059 (Dudley et al. 1995)
that specifically blocks activation of the ERK kinases
does not inhibit stem cell colony formation in response
to LIF (T. Burdon, I. Chambers, C. Stracey, J. Nichols,
and A.G. Smith, in prep.). Thus, although contributions
of other pathways are not precluded, STAT3 appears to
play a central role in ES cell self-renewal. The underlying
importance of STAT3 is further attested to by the finding
that homozygous disruption of the Stat3 gene in mice is
associated with early embryonic lethality (Takeda et al.
1997).
It is striking that the role of STAT3 in propagation of
the undifferentiated pluripotential phenotype of ES cells
contrasts with previously characterized functions as an
effector of somatic cell differentiation. Dominant inter-
fering mutants of STAT3 have been shown to block mac-
rophage differentiation of myeloid M1 cells induced by
IL-6 or LIF (Minami et al. 1996; Nakajima et al. 1996) or
by GCSF (Shimozaki et al. 1997). STAT3 activation has
similarly been shown to mediate IL-6- or LIF-induced
astrocytic differentiation of primary cortical neuroepi-
thelial cells (Bonni et al. 1997). Recently it has also been
shown that STAT3 is activated by hepatocyte growth
factor and mediates epithelial tubulogenesis (Boccaccio
et al. 1998). STAT3 thus has distinct effects in different
cell types. A common theme, however, may be the regu-
lation of genes that determine cell identity. The diverse
effects of the LIF/IL-6 family of cytokines on cellular
differentiation and gene expression appear to reflect cell-
type specific effects of active STAT3. In the context of
stem cell propagation, the key issue now is to identify
transcriptional targets of STAT3 in ES cells and to illu-
minate the relationship between STAT3 and the essen-
tial ES cell-specific transcription factor Oct-4.
Materials and methods
Cell culture and transfection
ES cells were maintained in the absence of feeder cells in
Glasgow modification of Eagle medium (GMEM) supplemented
with fetal calf serum, 2-mercaptoethanol, and LIF (Smith 1991).
CGR8 (Mountford et al. 1994) and MG1.19 (Gassmann et al.
1995) ES cells have been described elsewhere. DO27 ES cells
have had both copies of the lif gene inactivated by homologous
recombination and the IRESbgeo selection marker/reporter in-
serted into the oct4 gene as described (C. Dani, I. Chambers, S.
Johnstone, M. Robertson, B. Ebrahimi-Chahardahcherik, M.
Saito, T. Taga, M. Li, T. Burdon, J. Nichols, and A.G. Smith, in
prep.). LRKOh34 ES cells have targeted disruptions in both cop-
ies of the lifr gene (M. Li, I. Chambers, J. Nichols, and A.G.
Smith, in prep.) and are maintained in medium in which LIF is
substituted with IL-6 (50 ng/ml) and soluble IL-6 receptor (5%
CHO-5E7 conditioned medium; Yasukawa et al. 1990). For con-
ventional transfection with pPCAGIZ vectors, 1 × 107 cells
were electroporated with 100 µg of linearized plasmid DNA at
800 V and 3 µF in a 0.4-cm cuvette using a Bio-Rad gene pulser
and then selected in the presence of zeocin (Invitrogen). For
transfection of episomal vectors (supertransfection), 5 × 106
MG1.19 cells were electroporated with 20 µg of supercoiled
plasmid DNA at 200 V and 960 µF and then cultured in the
presence of either 80 µg/ml hygromycin B (Boehringer Mann-
heim) or 4–20 µg/ml blasticidin S (Waken Seiyaku), or both
hygromycin plus blasticidin for cosupertransfection.
Generation of tetracycline regulatable transgenes in ES cells
ZHTc6 ES cells were derived from CGR8 ES cells (Mountford et
al. 1994) and will be described in detail elsewhere (H. Niwa and
A.G. Smith, in prep.). They carry a targeted integration of
IRESzeo in one Oct3/4 allele. They also carry a gene trap inte-
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gration of an IREShph:CAGtTA construct that confers stable
expression of the tetracycline-responsive tTA transactivator
and a randomly integrated hCMV*-1–Oct4–IRESbgeopA trans-
gene. These cells were routinely maintained in the presence of
10 µg/ml zeocin and 1 µg/ml tetracycline-HCl (Sigma).
The hCMV*-1–Oct–4-IRESbgeopA transgene is comprised of
the tetracycline-inducible promoter hCMV*-1 derived from
pUHD10-3 (Gossen and Bujard 1992), rabbit b-globin second
intron, full-length Oct-4 cDNA, and IRESbgeopA unit (Mount-
ford et al. 1994). pSuperKO (see Fig. 5A) contains the hCMV*-1
and rabbit globin sequences as the 58 homology arm and the
IRESlacZ cassette as 38 arm. Intervening are a stuffer sequence
with XhoI and SfiI cloning sites and a loxP-flanked MC1tk cas-
sette (Mansour et al. 1988). The STAT3F cDNA was introduced
as a SalI fragment between the XhoI sites. For gene targeting,
2 × 107 cells were electroporated with 100 µg linearized Su-
perKO–STAT3F plasmid DNA at 800 V and 3 µF and then se-
lected in the presence of 200 µg/ml G418 (GIBCO BRL) and 1
µg/ml tetracycline-HCl. Targeted clones were maintained in
the continuous presence of tetracycline-HCl.
Plasmid construction
DNA manipulations were performed by standard procedures
(Sambrook et al. 1989). Full details of plasmid constructions are
available on request. The full-length mouse G-CSF-R cDNA
(pJ17) was provided by Shigekazu Nagata (Fukunaga et al. 1990),
and the G-CSF-R/LIF-R chimeric receptor construct (Baumann
et al. 1994b) was provided by Steve Ziegler. G-CSF-R/gp130
chimeric receptor constructs were generated by fusing the cod-
ing sequence for the extracellular domain of human G-CSF-R
(Baumann et al. 1994b) to an EcoRI fragment encoding the trans-
membrane domain and the entire cytoplasmic region of mouse
gp130 cDNA (Hibi et al. 1990). Phenylalanine substitutions
were introduced into the intracellular domain of gp130 by PCR
overlap mutagenesis (Higuchi et al. 1988). PCR products were
substituted into the G-CSF-R/gp130 chimera and sequenced.
Episomal expression vectors pHPCAG, pBPCAG, and pHPPGK
are described elsewhere (H. Niwa, I. Chambers, L. Forrester, M.
Gassmann, and A.G. Smith, in prep.). The expression vector
pPCAGIZ, which can be used as both an episomal and an inte-
grated expression vector, was constructed by ligation of the en-
cephalomyocarditis virus IRES (pCITE-1, Novagen) with the
Streptoalloteichus bleomycin resistant gene (Sh ble:zeo) from
pZeoSV (Invitrogen) and introduction into pPCAG (H. Niwa, I.
Chambers, L. Forrester, M. Gassmann, and A.G. Smith, in
prep.). cDNAs are inserted into a XhoI site 58 to the IRES. The
requirement for continuous relatively high-level expression of
the zeo gene to confer antibiotic resistance allows direct selec-
tion for integrations into favorable expression sites. Conse-
quently, using this vector, ES cell transfectants can readily be
isolated that sustain stable transgene expression (H. Niwa, T.
Burdon, I. Chambers, and A.G. Smith, unpubl.).
RNA and DNA hybridization analyses
Total RNA (Chomczynski and Sacchi 1987) was separated on a
0.66 M formaldehyde, 0.8% agarose gel and blotted onto nylon
membranes (Hybond N, Amersham). Hybridization was per-
formed with b-globin third exon, Rex-1, H19, and GAPDH
cDNA probes labeled by random hexamer primed DNA synthe-
sis in the presence of [a-32P]dCTP (3000 Ci/mmole).
For identification of targeted ES cell clones, genomic DNA
was digested with SacI, separated on a 0.7% agarose gel, and
analyzed by nonradioactive filter hybridization (Gene Image,
Amersham) with an EcoRI–SacI fragment of the lacZ gene.
G-CSF-R binding assay
ES cells (1 × 106) were seeded in wells of a 24-well plate and
grown for 24 hr. The cells were then cooled to 4°C and growth
medium was replaced with 0.25 ml of ice-cold binding buffer
(GMEM, 25 mM HEPES at pH 7.2, 0.2% BSA) containing 0.212
nM 125I-labeled G-CSF-R (Amersham) in the presence or absence
of a 1000-fold molar excess of cold G-CSF-R. Binding reactions
were incubated for 3 hr at 4°C and terminated by washing the
cells three times with ice-cold binding buffer. Cells were then
solubilized in 0.5% NP-40, and an aliquot was counted in a
gamma counter. All treatments were performed in duplicate.
No specific binding was detected to untransfected cells, and
nondisplaceable binding was consistent between clones.
Self-renewal assays
To measure self-renewal of ES cells at cloning density, cells
were plated at 1000 cells per well (∼100 cells/cm2) in 6-well
dishes and cultured for 6 days. Cells were either grown in the
absence of cytokines, in 100 U/ml recombinant LIF (Smith
1991), in 100 ng/ml IL-6 plus soluble IL-6R, or in 30 ng/ml
G-CSF-R, as appropriate. On day 6, colonies were fixed and
stained with Leishman’s reagent (Smith 1991) or for alkaline
phosphatase activity (Sigma leukocyte alkaline phosphatase kit)
(Bernstine et al. 1973). Numbers of stem cell and differentiated
colonies were scored by microscopic examination, in some
cases with computer-assisted image analysis. All assays were
performed in duplicate or triplicate.
Stem cell-specific expression of b-galactosidase from the oct4
locus in D027 cells was quantified by ONPG assay on triplicate
samples. Cells were plated at 5000 per well in 24-well dishes
and cultured for 6 days in the presence or absence of cytokine as
above. On day 6, cells were washed once with PBS and lysed in
0.4 ml of 0.25 M Tris (pH 7.5), 5 mM DTT, and 0.5% NP-40.
Lysate (40 µl) was mixed with 100 µl of ONPG buffer (60 mM
Na2HPO4, 40 mM NaH2PO4, 10 mM KCl, 1 mM MgCl2, 50 mM
2-mercaptoethanol, 1.2 mM ONPG) in a microtiter plate and
incubated at 37°C for 2–4 hr, and the absorbance was read at
420 nm.
Preparation of nuclear extracts and band-shift assays
One day after plating (1 × 106 cells per 60-mm dish), ES cells
were washed with PBS and refed with medium lacking cyto-
kines. The next day, cells were stimulated with IL-6 (100 ng/ml
plus soluble receptor) or G-CSF-R (30 ng/ml) for 30 min, washed
with ice-cold PBS, scraped off the plates, and collected by cen-
trifugation. Nuclear extracts were prepared by the method de-
scribed (Gobert et al. 1996) except that protease inhibitors (apro-
tinin, pepstatin, and leupeptin) were omitted from the cell lysis
buffer. Protein concentrations of nuclear extracts were deter-
mined using a Bradford assay (Bio-Rad). Aliquots (2 µg) of
nuclear extract were incubated with 0.25 ng of 32P-labeled
double-stranded SIEm67 oligonucleotide probe (Sadowski et al.
1993) in binding buffer (20 mM HEPES at pH 7.5, 50 mM NaCl,
1 mM EDTA, 1 mM DTT, 0.05% NP-40, 10% glycerol, 2 µg/ml
of poly[d(I-C)], and 1 mg/ml BSA) for 20 min at room tempera-
ture. Binding reactions were resolved by electrophoresis on a
prerun 5% polyacrylamide gel in 0.25× TBE for 3 hr. Gels were
fixed in 10% acetic acid, dried under vacuum, and subjected to
autoradiography or quantitated on a Bio-Rad PhosphorImager.
Immunoblotting
One day after plating (1 × 106 cells per 60-mm dish), ES cells
were refed with medium containing 1% FCS and lacking cyto-
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kines. Following overnight incubation, cells were transferred to
serum-free medium for 4 hr prior to stimulation with IL-6 (100
ng/ml plus soluble receptor) or G-CSF-R (30 ng/ml) for 20 min.
Cells were then washed once with ice-cold PBS and lysed on ice
in 100 µl SDS sample buffer. Ten- microliter aliquots of the
lysates were fractionated on a 10% SDS–polyacrylamide gel and
electroblotted onto nitrocellulose. After overnight treatment in
blocking buffer (25 mM Tris-HCl at pH 7.4, 2.7 mM KCl, 140 mM
NaCl, 0.1% Tween 20, 5% nonfat dried milk), membranes were
probed sequentially with the phospho-specific anti-ERK and
anti-STAT3 antibodies according to the directions provided by
the supplier (New England Biolabs). Blots were incubated with
HRP-coupled anti-rabbit IgG and developed using ECL reagents
(Amersham). Membranes were stripped between probings by
incubation at 50°C for 30 min in 62.5 mM Tris-HCl (pH 6.8), 2%
SDS, and 100 mM 2-mercaptoethanol.
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